Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

Anterior segment mesenchymal dysgenesis

From Wikipedia, the free encyclopedia
Medical condition
Anterior segment mesenchymal dysgenesis
Other namesAnterior segment dysgenesis
Anterior segment mesenchymal dysgenesis is inherited in anautosomal dominant manner.
SpecialtyMedical genetics Edit this on Wikidata

Anterior segment mesenchymal dysgenesis, or simplyanterior segment dysgenesis, is a failure of the normal development of the tissues of theanterior segment of the eye. It leads to anomalies in the structure of the mature anterior segment, associated with an increased risk ofglaucoma andcorneal opacity.

Peters' (frequently misspelled asPeter's)anomaly is a specific type ofmesenchymal anterior segment dysgenesis, in which there is central corneal leukoma, adhesions of theiris andcornea and abnormalities of the posteriorcorneal stroma,Descemet's membrane,corneal endothelium,lens andanterior chamber.[1]

Presentation

[edit]
[icon]
This section is empty. You can help byadding to it.(November 2025)

Pathophysiology

[edit]

Several gene mutations have been identified underlying these anomalies, with the majority of anterior segment dysgenesis genes encodingtranscriptional regulators. In this review, the role of the anterior segment dysgenesis genesPITX2 andFOXC1 is considered in relation to the embryology of the anterior segment, the biochemical function of these proteins, and their role in development and diseaseaetiology. The emerging view is that these genes act in concert to specify a population of mesenchymal progenitor cells, mainly ofneural crest origin, as they migrate anteriorly around the embryonicoptic cup. These same genes then regulatemesenchymal cell differentiation to give rise to distinct anterior segment tissues. Development appears critically sensitive togene dosage, and variation in the normal level oftranscription factor activity causes a range of anterior segment anomalies. Interplay betweenPITX2 andFOXC1 in the development of different anterior segment tissues may partly explain the phenotypic variability and the genetic heterogeneity characteristic of anterior segment dysgenesis. In the most recent research, thePAX6 gene has been implicated in Peters' Anomaly.[2]

Diagnosis

[edit]
[icon]
This section is empty. You can help byadding to it.(November 2025)

Management

[edit]

There is no standard treatment approval, yet numerous surgical techniques have been tried during the latest years, including: penetrating keratoplasty,[3] cataract aspiration or lensectomy,[4][5] optical iridectomy,[6] selective endothelial removal,[7] trabeculectomy and implant of glaucoma draining devices.[8] However, postoperative outcomes are not very promising due to severe amblyopia and other ocular complications, including glaucoma or retinal detachment.[citation needed]

History

[edit]

This congenital anomaly was first described by German ophthalmologist Albert Peters (1862–1938).[9]

References

[edit]
  1. ^Pomella, K. M.; Wagner, H. (1998). "Unilateral Peters' anomaly complicated by a corneal tattoo".Optometry and Vision Science.75 (9):635–639.doi:10.1097/00006324-199809000-00017.PMID 9778695.
  2. ^Sault, R. W., & Sheridan, J. (2013). Peters' Anomaly. Ophthalmology and Eye Diseases, 5, 1–3.http://doi.org/10.4137/OED.S11142
  3. ^Zaidman, Gerald W.; Flanagan, Jessica K.; Furey, Catherine C. (July 2007)."Long-term Visual Prognosis in Children after Corneal Transplant Surgery for Peters Anomaly Type I".American Journal of Ophthalmology.144 (1): 104–108.e1.doi:10.1016/j.ajo.2007.03.058.PMID 17601429.
  4. ^Tătaru, C. I.; Tătaru, C. P.; Preoteasa, L. D. (2022-05-02)."Surgical approach in type II Peters anomaly – case report"(PDF).Romanian Journal of Ophthalmology.66 (1):101–108.doi:10.22336/rjo.2022.20.PMC 9022142.PMID 35531449.
  5. ^Li, Zhangliang; Zou, Rui; Zhao, Yune (December 2020)."Keratolenticular adhesion removal for type 2 Peters anomaly: a case report".Eye and Vision.7 (1): 39.doi:10.1186/s40662-020-00203-5.ISSN 2326-0254.PMC 7350768.PMID 32676510.
  6. ^Spierer, Oriel; Cavuoto, Kara M.; Suwannaraj, Sirinya; McKeown, Craig A.; Chang, Ta Chen (September 2018)."Outcome of optical iridectomy in Peters anomaly".Graefe's Archive for Clinical and Experimental Ophthalmology.256 (9):1679–1683.doi:10.1007/s00417-018-4000-2.ISSN 0721-832X.PMID 29705837.
  7. ^Soh, Yu Qiang; Mehta, Jodhbir S. (March 2018)."Selective Endothelial Removal for Peters Anomaly".Cornea.37 (3):382–385.doi:10.1097/ICO.0000000000001472.ISSN 0277-3740.PMID 29408830.
  8. ^van Oterendorp, Christian (June 2019)."Glaukomchirurgie bei Vorderabschnittsdysgenesien".Klinische Monatsblätter für Augenheilkunde (in German).236 (6):745–750.doi:10.1055/a-0839-9091.ISSN 0023-2165.PMID 31049915.
  9. ^doctor/3158 atWhonamedit?

External links

[edit]
Classification
External resources
Genetic disorders relating to deficiencies oftranscription factor or coregulators
(1) Basic domains
1.2
1.3
(2) Zinc finger
DNA-binding domains
2.1
2.2
2.3
2.5
(3) Helix-turn-helix domains
3.1
3.2
3.3
3.5
(4) β-Scaffold factors
with minor groove contacts
4.2
4.3
4.7
4.11
(0) Other transcription factors
0.6
Ungrouped
Transcription coregulators
Coactivator:
Corepressor:
Retrieved from "https://en.wikipedia.org/w/index.php?title=Anterior_segment_mesenchymal_dysgenesis&oldid=1324778895"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2026 Movatter.jp